CRIZALK

Serial Number 85069603
606

Registration Progress

Application Filed
Jun 23, 2010
Under Examination
Jan 11, 2011
Approved for Publication
Nov 16, 2010
Published for Opposition
Nov 16, 2010
Registered

Trademark Image

CRIZALK

Basic Information

Serial Number
85069603
Filing Date
June 23, 2010
Published for Opposition
November 16, 2010
Abandonment Date
August 15, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 15, 2011
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Cindy M. Zelson

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

11 events
Date Code Type Description Documents
Aug 15, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 15, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 11, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 16, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 16, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 13, 2010 ALIE A ASSIGNED TO LIE Loading...
Oct 13, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 29, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 28, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 28, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 26, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005